The Role of GLP-1 Receptor Signalling in the Glucose-lowering Effect of Metformin in Patients With T2D

NCT03246451 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Glucose Metabolism Disorders

Interventions

DRUG: Placebo Oral Tablet
DRUG: Metformin
DRUG: Saline
DRUG: Exendin (9-39)

Sponsor

University Hospital, Gentofte, Copenhagen

Collaborators

[object Object]